Učitavanje...

Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia

Since December 2019, a novel coronavirus pneumonia (COVID-19) has broken out in Wuhan, China and spread rapidly. Recent studies have found that ⁓ 15.7% of patients develop severe pneumonia, and cytokine storm is an important factor leading to rapid disease progression. Currently, there are no specif...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Drug Investig
Glavni autori: Zhang, Shengyu, Li, Lei, Shen, Aizong, Chen, Yongwu, Qi, Zhigang
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7183818/
https://ncbi.nlm.nih.gov/pubmed/32337664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-020-00917-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!